185 related articles for article (PubMed ID: 23868334)
1. Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.
Zanotti-Fregonara P; Lammertsma AA; Innis RB
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1781-3. PubMed ID: 23868334
[No Abstract] [Full Text] [Related]
2. Positron-emitting radiopharmaceuticals: how safe are they?
Silberstein EB
Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
[No Abstract] [Full Text] [Related]
3. Safety of 18F-DOPA injection for PET of carcinoid tumor.
Nataf V; Balard M; de Beco V; Kerrou K; Gutman F; Grahek D; Montravers F; Talbot JN
J Nucl Med; 2006 Oct; 47(10):1732; author reply 1732. PubMed ID: 17015913
[No Abstract] [Full Text] [Related]
4. Comparison of the biological effects of (18)F at different intracellular levels.
Kashino G; Hayashi K; Douhara K; Kobashigawa S; Mori H
Biochem Biophys Res Commun; 2014 Nov; 454(1):7-11. PubMed ID: 25301551
[TBL] [Abstract][Full Text] [Related]
5. Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval.
Cortes-Blanco A; Prieto-Yerro C; Martinez-Lazaro R; Zamora J; Jiménez-Huete A; Haberkamp M; Pohly J; Enzmann H; Zinserling J; Strassmann V; Broich K
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S395-9. PubMed ID: 24418060
[TBL] [Abstract][Full Text] [Related]
6. Radiation dosimetry of [
Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
[TBL] [Abstract][Full Text] [Related]
7. Occupational Exposure to Veterinary Workers from the Positron Emission Tomography Imaging Agent 64Cu-ATSM.
Hetrick LD; Kraft SL; Johnson TE
Health Phys; 2015 Nov; 109(3 Suppl 3):S219-23. PubMed ID: 26425985
[TBL] [Abstract][Full Text] [Related]
8. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
[TBL] [Abstract][Full Text] [Related]
9. An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.
Senda M; Yamamoto Y; Sasaki M; Yamane T; Brooks DJ; Farrar G; McParland B; Heurling K
Ann Nucl Med; 2015 Jun; 29(5):391-9. PubMed ID: 25874747
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-fluoride PET/computed tomography imaging.
Even-Sapir E
PET Clin; 2014 Jul; 9(3):277-85. PubMed ID: 25030391
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans.
Herrero P; Laforest R; Shoghi K; Zhou D; Ewald G; Pfeifer J; Duncavage E; Krupp K; Mach R; Gropler R
J Nucl Med; 2012 Jun; 53(6):994-1001. PubMed ID: 22582045
[TBL] [Abstract][Full Text] [Related]
12. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
Allott L; Aboagye EO
Mol Pharm; 2020 Jul; 17(7):2245-2259. PubMed ID: 32433888
[TBL] [Abstract][Full Text] [Related]
13. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
Siderowf A; Pontecorvo MJ; Shill HA; Mintun MA; Arora A; Joshi AD; Lu M; Adler CH; Galasko D; Liebsack C; Skovronsky DM; Sabbagh MN
BMC Neurol; 2014 Apr; 14():79. PubMed ID: 24716655
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.
Kranz M; Sattler B; Wüst N; Deuther-Conrad W; Patt M; Meyer PM; Fischer S; Donat CK; Wünsch B; Hesse S; Steinbach J; Brust P; Sabri O
Molecules; 2016 Sep; 21(9):. PubMed ID: 27598110
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins?
Choyke PL
Radiology; 2011 Jul; 260(1):1-2. PubMed ID: 21697304
[TBL] [Abstract][Full Text] [Related]
18. Ramatroban-Based Analogues Containing Fluorine Group as Potential
Huang LA; Huang KX; Tu J; Kandeel F; Li J
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
[TBL] [Abstract][Full Text] [Related]
19. Bilateral multiple pulmonary (18)F-FDG microembolisms demonstrated on PET/CT.
Gungor S; Mazican M; Koc I; Bal H; Mazican N
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):333-4. PubMed ID: 25771093
[No Abstract] [Full Text] [Related]
20. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
